Why Older Lifespan Heritability Estimates Were So Low
For decades, the prevailing scientific consensus suggested that genetics accounted for a mere 20% to 25% of human life span variation, with recent large-scale pedigree studies even pushing that estimate as low as 6%. This data led many to believe that our biological "hardware" was largely overshadowed compared to environmental factors and lifestyle choices. However, researchers identified a significant discrepancy: these low estimates were inconsistent with the higher heritability observed in other species and most other complex human physiological traits, which average around 49%.
The Key Concept: Extrinsic Mortality vs Intrinsic Aging
The primary objective of this 2026 study was to determine if these historical estimates were failing to properly account for "extrinsic mortality".
What are extrinsic and intrinsic mortality?
extrinsic mortality: deaths resulting from external factors like infections, accidents, and environmental hazards that occur regardless of an individual's underlying biological health.
intrinsic mortality: mortality resulting from processes originating within the body, such as genetic mutations, the decline of physiological function, and age-related diseases. It is characterized by an exponential increase in risk over time, reflecting the underlying biological program of aging.
The Methods Used: SR and Makeham-Gamma-Gompertz Models
To isolate the true genetic signal, the research team employed two advanced mathematical frameworks: the Saturating-Removal (SR) model, which simulates the interplay between biological damage and the body's repair mechanisms, and the Makeham-Gamma-Gompertz (MGG) model, a statistical framework used to partition mortality into intrinsic and extrinsic components. They applied these filters to expansive datasets, including two Danish and Swedish twin registries and the SATSA cohort, which uniquely includes twins reared both together and apart, representing an ideal approach for separating genetic influence from shared childhood environments. By mathematically removing the "noise" of extrinsic deaths and standardizing the data to a "Heritability of Intrinsic Life span" (HIL), they were able to reveal a more precise estimate of the genetic contribution to variability in human lifespan.
The Results: Intrinsic Lifespan Heritability Rises To ~55%
The results represent a paradigm shift in geroscience: once extrinsic mortality is properly addressed, the contribution of heritability to variability in the human life span is approximately 55%, more than doubling previous estimates. This finding aligns longevity with other major human traits and suggests that our genetic blueprint is a far more dominant factor in our biological "ceiling" than previously recognized.
How Genetics Shapes Disease Risk: Heart Disease, Dementia, and Cancer
Crucially, the study revealed that genetic influence is not static; it is a collection of disease-specific "clocks". For instance, the genetic risk for dying from cardiovascular disease (CVD) or dementia is remarkably high - reaching heritability levels of 0.5 to 0.7 - in the decades leading up to age 80. However, for those who survive past age 90, the genetic signal for these specific killers effectively fades, leaving continued survival to be dictated more by biological stochasticity and cumulative lifestyle factors.
Practical Takeaways: What To Do With A 55% Heritability Signal
Given that more than half the variability in intrinsic life span is dictated by heritable factors, these findings should not lead to fatalism, but rather to more targeted and aggressive personal health management. Because your "hardware" exerts such a strong influence on your risk profile through age 80, the following recommendations are essential for an evidence-informed comprehensive health strategy:
Prioritize Family History
With a 55% heritability rate, your relatives’ health histories are powerful predictors; a family history of dementia (0.7 heritability) or CVD (0.5 heritability) necessitates early and aggressive preventive screenings.
Aggressive Early Intervention
Since the genetic "weight" of CVD and dementia is highest before age 80, your 40s, 50s, and 60s are the critical window to use lifestyle "overrides,"such as rigorous aerobic capacity training and metabolic optimization,to mitigate these genetic liabilities.
Maintain Lifelong Cancer Surveillance
Unlike other diseases, the genetic risk for cancer remains a steady factor (~0.3 heritability) throughout your entire life, meaning screening protocols should never be relaxed, regardless of age.
Focus on the 45%
While genetics set the baseline, approximately 45% of the variance remains under your control through lifestyle, environment, and the avoidance of modern extrinsic risks, such as metabolic dysfunction.
Conclusion: Why The Standard Annual Physical May Be Insufficient
If genetics account for approximately 55% of biological aging variability, the "standard" annual physical is insufficient for detecting the early-stage disease risks that define your trajectory. Biograph bridges this gap by replacing generic screening with a deep-dive diagnostic protocol designed to identify risks in the critical window before age 80. We’re working towards the physical of the future.
How Biograph Benefits the "High-Heritability" Individual
Biograph’s model directly addresses the four pillars of risk highlighted in the research:
Identifying Your Genetic "Floor"
Since intrinsic lifespan is highly heritable, your family history provides a script that Biograph helps you read through data. By screening for Hereditary Diseases and utilizing Multi-Modal Brain Health assessments, the clinic can help clarify the underlying genetic risk for dementia (heritability ~0.7) identified in the study.
Navigating the "80-Year Pivot"
The research indicates that genetic contribution to Cardiovascular Disease (CVD) and Dementia risk is highest before age 80. Biograph targets this specific timeframe with:
CT Coronary Angiography (CCTA): To detect arterial plaque in asymptomatic individuals, allowing for early "lifestyle overrides".
MRI Brain Imaging: To detect early evidence of cerebral microvascular disease allowing for early aggressive interventions to reduce the risk of progression
Constant Surveillance for Steady-State Risks
Unlike heart disease, the genetic risk for Cancer remains steady (~0.3 heritability) throughout life. Biograph addresses this risk with a set of overlapping tools designed for early cancer detection to supplement traditional cancer surveillance guidelines:
Whole-Body MRI: Designed to detect abnormalities and early evidence of worrisome lesions in the head, neck and body..
Multi-Cancer Early Detection (MCED) Blood Tests: To catch early signals of cancers for which there are no current established surveillance protocols
Low-Dose Chest CT: To screen for early lung cancer in appropriate individuals, particularly those with elevated risk based on age or smoking history.
Optimizing the "Other 45%"
While your genes set the baseline, lifestyle choices account for nearly half of the variance in your lifespan. Biograph uses clinical data to personalize these levers:
VO2 Max and DEXA Testing: To measure your aerobic capacity and muscle mass - critical markers for functional longevity.
Personalized Coaching: Expert-led guidance on nutrition, exercise, and sleep to ensure your "software" is running optimally to support your genetic "hardware".
Common Questions About Genetics and Longevity
How much of human lifespan is determined by genetics?
Recent research suggests that genetics may account for a much larger share of human lifespan variation than previously thought. When deaths from external causes are separated from biological aging, studies estimate that genetics may explain roughly half of the variability in intrinsic lifespan.
What is intrinsic lifespan?
Intrinsic lifespan refers to longevity determined by biological aging processes rather than external events. It reflects how long someone might live if deaths from accidents, infections, and other external factors were removed from the analysis.
What is extrinsic mortality?
Extrinsic mortality refers to deaths caused by external factors such as accidents, infections, violence, or environmental hazards. These events occur independently of an individual’s biological aging and can obscure the underlying genetic contribution to lifespan.
Why did older studies estimate lower genetic influence on lifespan?
Earlier lifespan studies often failed to separate deaths caused by aging from deaths caused by external factors. Because extrinsic mortality introduces statistical noise into lifespan data, genetic contributions to biological aging were likely underestimated in previous research.
Does having longevity genes guarantee a long life?
No. Genetics influence lifespan potential, but they do not determine outcomes alone. Lifestyle, environment, medical care, and chance events still play major roles in how long someone lives and how healthy they remain over time.
How do genetics influence diseases related to aging?
Genetics can shape an individual’s risk for major age-related diseases such as cardiovascular disease, dementia, and cancer. These genetic influences often interact with lifestyle and environmental factors, which means disease risk can still be modified through prevention and early intervention.
Why is early detection important if genetics play a large role in lifespan?
Even when genetic risk is high, many diseases develop gradually over decades before symptoms appear. Early detection allows physicians to identify risk earlier and intervene while biological changes are still modifiable.
Can lifestyle choices still influence longevity if genetics are important?
Yes. While genetics may set the biological baseline for lifespan, lifestyle and environmental factors still influence health outcomes. Factors such as physical fitness, metabolic health, sleep quality, and preventive care can significantly affect long-term health and functional longevity.
About the Author
Dr. Michael Doney is Biograph’s Executive Medical Director, overseeing our clinical team. He has been practicing for 20 years and received his board certification in Emergency Medicine.
Clinical References
Zhang Y, et al. The moleceadz1187. doi:10.1126/science.adz1187024;385(6707):eadz1187. doi:10.1126/science.adz1187. https://www.science.org/doi/10.1126/science.adz1187
